Biotech Values

[dewophile]

Getting high rates of cure in hep B may be a rather long shot altogether but curious why you are bearish on RNAi in particular. Seems to me the ability to lower HBSAg (albeit modestly) w data to date is still much better than you could ever get with a nuke. Seems like at least a step in the right direction to me